Challenges in the sequencing of therapies for the management of metastatic castration-resistant prostate cancer.
about
Treatment Sequences and Pharmacy Costs of 2 New Therapies for Metastatic Castration-Resistant Prostate Cancer.Kaiso, a transcriptional repressor, promotes cell migration and invasion of prostate cancer cells through regulation of miR-31 expression.Cabazitaxel in patients with metastatic castration-resistant prostate cancer: safety and quality of life data from the Australian early access program.Rapid bench to bed in management of metastatic prostate cancer
P2860
Challenges in the sequencing of therapies for the management of metastatic castration-resistant prostate cancer.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Challenges in the sequencing o ...... ion-resistant prostate cancer.
@en
type
label
Challenges in the sequencing o ...... ion-resistant prostate cancer.
@en
prefLabel
Challenges in the sequencing o ...... ion-resistant prostate cancer.
@en
P2860
P356
P1476
Challenges in the sequencing o ...... ion-resistant prostate cancer.
@en
P2093
Francis Parnis
Phillip Parente
P2860
P304
P356
10.1111/AJCO.12193
P577
2014-04-03T00:00:00Z